LEADER 02239nam  2200565   450 
001 9910825712603321
005 20230803030543.0
010   $a1-78084-207-4
035   $a(CKB)2670000000391289
035   $a(EBL)1179630
035   $a(OCoLC)851970658
035   $a(SSID)ssj0001526192
035   $a(PQKBManifestationID)11834621
035   $a(PQKBTitleCode)TC0001526192
035   $a(PQKBWorkID)11505974
035   $a(PQKB)10487917
035   $a(MiAaPQ)EBC1179630
035   $a(Au-PeEL)EBL1179630
035   $a(EXLCZ)992670000000391289
100   $a20220517d2013      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aCancer cachexia /$feditors Josep M. Argile?s, Silvia Busquets
205   $a1st ed.
210  1$aLondon, England :$cFuture Medicine Ltd.,$d[2013]
210  4$dİ2013
215   $a1 online resource (77 p.)
300   $aDescription based upon print version of record.
311   $a1-78084-209-0 
327   $aTitle page; Copyright page; Contents; Foreword. Cancer cachexia; 1. Prevalence and clinical features of cancer cachexia; 2. Pathogenesis of cancer cachexia; 3. Current medications for cancer cachexia; 4. Latest developments in cachexia drug discovery: clinical trials; 5. Comorbidities and prognosis; Index
330   $aCancer cachexia is a multiorganic syndrome associated with neoplastic syndromes, characterized by a marked weight loss, anorexia, asthenia and anemia. This expertly authored book provides a comprehensive review of the mechanisms, mediators and treatment of cancer cachexia. The book represents a comprehensive expert review and summary of the current status of cancer cachexia and its therapy.
606   $aCancer$xNutritional aspects
606   $aCachexia
606   $aCachexia$xTreatment
615  0$aCancer$xNutritional aspects.
615  0$aCachexia.
615  0$aCachexia$xTreatment.
676   $a616.9940654
702   $aArgile?s$b Josep M.
702   $aBusquets$b Silvia
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910825712603321
996   $aCancer cachexia$93921496
997   $aUNINA